These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35653055)

  • 1. Ischemia Trial: Does the Cardiology Community Need to Pivot or Continue Current Practices?
    Jafary FH; Jafary AH
    Curr Cardiol Rep; 2022 Aug; 24(8):1059-1068. PubMed ID: 35653055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
    Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Alexander KP; Senior R; Boden WE; Stone GW; Goodman SG; Lopes RD; Lopez-Sendon J; White HD; Maggioni AP; Shaw LJ; Min JK; Picard MH; Berman DS; Chaitman BR; Mark DB; Spertus JA; Cyr DD; Bhargava B; Ruzyllo W; Wander GS; Chernyavskiy AM; Rosenberg YD; Maron DJ;
    JAMA Cardiol; 2019 Mar; 4(3):273-286. PubMed ID: 30810700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease.
    Paul TK; Mamas MA; Shanmugasundaram M; Nagarajarao HS; Ojha CP; Jneid H; Kumar G; White CJ
    Curr Cardiol Rep; 2021 Mar; 23(4):23. PubMed ID: 33655382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges with Evidence-Based Management of Stable Ischemic Heart Disease.
    Patel AV; Bangalore S
    Curr Cardiol Rep; 2017 Feb; 19(2):11. PubMed ID: 28185167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists.
    Maron DJ; Stone GW; Berman DS; Mancini GB; Scott TA; Byrne DW; Harrell FE; Shaw LJ; Hachamovitch R; Boden WE; Weintraub WS; Spertus JA
    Am Heart J; 2011 Dec; 162(6):1034-1043.e13. PubMed ID: 22137077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    Stone GW; Hochman JS; Williams DO; Boden WE; Ferguson TB; Harrington RA; Maron DJ
    J Am Coll Cardiol; 2016 Jan; 67(1):81-99. PubMed ID: 26616030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.
    Kones R
    Vasc Health Risk Manag; 2010 Sep; 6():749-74. PubMed ID: 20859545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemia is the critical determinant of revascularization benefit: an interventionalist's perspective of the COURAGE trial.
    Kereiakes DJ
    Rev Cardiovasc Med; 2009; 10 Suppl 2():S45-52. PubMed ID: 19898281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
    Cheng-Torres KA; Desai KP; Sidhu MS; Maron DJ; Boden WE
    Future Cardiol; 2016 Jan; 12(1):35-44. PubMed ID: 26696561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond.
    Weintraub WS; Mancini GBJ; Boden WE
    Int J Cardiol; 2023 Feb; 373():39-43. PubMed ID: 36427605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the ISCHEMIA Trial Apply to My Patients?
    Upadhyaya V; Gowda SN; Porto G; Bavishi CP; Sardar P; Bashir R; Gokceer ME; Chatterjee S
    Curr Cardiol Rep; 2022 Jun; 24(6):653-657. PubMed ID: 35353329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population.
    Chatterjee S; Fanaroff AC; Parzynski C; Curtis J; Kolansky DM; Maddox TM; Mukherjee D; Yeh RW; Giri J
    JACC Cardiovasc Interv; 2021 Nov; 14(21):2344-2349. PubMed ID: 34736733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA.
    Phillips LM; Hachamovitch R; Berman DS; Iskandrian AE; Min JK; Picard MH; Kwong RY; Friedrich MG; Scherrer-Crosbie M; Hayes SW; Sharir T; Gosselin G; Mazzanti M; Senior R; Beanlands R; Smanio P; Goyal A; Al-Mallah M; Reynolds H; Stone GW; Maron DJ; Shaw LJ
    J Nucl Cardiol; 2013 Dec; 20(6):969-75. PubMed ID: 23963599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?
    Xie JX; Winchester DE; Phillips LM; Hachamovitch R; Berman DS; Blankstein R; Di Carli MF; Miller TD; Al-Mallah MH; Shaw LJ
    J Nucl Cardiol; 2017 Oct; 24(5):1610-1618. PubMed ID: 28752313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCI versus CABG versus medical therapy in 2006.
    Morrison D
    Minerva Cardioangiol; 2006 Oct; 54(5):643-72. PubMed ID: 17019400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease.
    Vafaei P; Naderi S; Ambrosy AP; Slade JJ
    Curr Atheroscler Rep; 2021 Sep; 23(11):70. PubMed ID: 34468881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.